文献速递多重用药衰弱、肌少症与跌倒

多药老年人群中CYP450多态性酶通路与跌倒的关联

Association of Polymorphic Cytochrome P450 Enzyme Pathways with Falls in Multimedicated Older Adults.
PubMed 文献 · J Am Med Dir Assoc · 2024-09-03

该前瞻性人群研究纳入1377名社区居住的老年多药使用者,分析CYP2C19、2C9和2D6多态性酶代谢与1年跌倒的关联。结果显示,经CYP2C19代谢的非跌倒风险增加药物(non-FRIDs)与跌倒相关(OR 1.46,95%CI 1.11-1.93),且CYP2C19活性降低表型对上述关联有显著效应修饰。

要点

  • 经CYP2C19代谢的非FRIDs药物与跌倒风险升高相关(OR 1.46)。
  • CYP2C19活性降低表型可显著修饰non-FRIDs代谢与跌倒的关联。
  • 基因型预测的表型本身与跌倒无显著关联。

核心结论

  • 老年多药使用者中,经CYP2C19代谢的非FRIDs药物使用与跌倒相关,且CYP2C19活性降低表型存在显著效应修饰。

研究设计与样本

  • 前瞻性人群研究(ActiFE-Ulm研究),纳入社区居住老年多药使用者,分析CYP2C19、2C9和2D6多态性酶代谢与1年跌倒的关联。

主要发现

  • 共1377名参与者纳入分析,经CYP2C19代谢的非FRIDs药物与跌倒的校正OR为1.46(95%CI 1.11-1.93)。
  • 基因型预测的CYP2C19表型本身与跌倒无显著关联。
  • CYP2C19活性降低表型对经CYP2C19代谢的non-FRIDs与跌倒的关联存在显著效应修饰。

关键数值与推荐

  • 经CYP2C19代谢的非FRIDs药物使用与跌倒关联的校正OR为1.46(95%CI 1.11-1.93)。

临床怎么用

  • 对使用CYP2C19底物药物(如部分抗抑郁药、阿片类、镇静剂及质子泵抑制剂)的老年多药使用者,可考虑个体化剂量与疗程,尤其针对弱代谢和中间代谢者。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Dose exposure is considered relevant for drug-associated falls in older adults, pointing to an importance of drug metabolism. Aim was to analyze individual factors altering drug metabolism such as enzyme saturation by drug exposure and pharmacogenetics in the context of drug-associated falls. DESIGN: Prospective population-based study (ActiFE-Ulm study). SETTING AND PARTICIPANTS: Community-dwelling older adults. METHODS: Focus was laid on the metabolism by polymorphic cytochrome P450 (CYP) enzymes CYP2C19, 2C9, and 2D6. Relevant variants of pharmacogenes were analyzed. Logistic binary regression analysis was used to calculate odds ratios (ORs) and 95% CIs for falls observed prospectively over a 1-year period with drug metabolism characteristics. RESULTS: In total, 1377 participants were included in the analysis. Although the phenotype predicted by the genotype was not, the use of drugs metabolized by CYP2C19 was associated with falls. Drugs not known as fall risk-increasing drugs (FRIDs; ie, non-FRIDs), but metabolized by CYP2C19, showed an OR of 1.46 (1.11-1.93) in adjusted analysis. Significant effect modification was observed for a reduced CYP2C19 activity phenotype with non-FRIDs metabolized by CYP2C19. CONCLUSIONS AND IMPLICATIONS: This study suggests an association between the occurrence of falls in older adults and the metabolic capacity of CYP2C19. Thus, an important step toward prevention of falls might be to personalize dosage and treatment length of the main drug classes known to be CYP2C19 substrates, such as many antidepressants, opioids, and sedatives, but also proton pump inhibitors in particular in poor and intermediate metabolizers.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Just KS, Pott LM, Sommer J, et al. Association of Polymorphic Cytochrome P450 Enzyme Pathways with Falls in Multimedicated Older Adults. J Am Med Dir Assoc. 2024. PMID: 39236770. doi:10.1016/j.jamda.2024.105235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。